Filing Details
- Accession Number:
- 0001140361-16-056843
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-07 17:33:47
- Reporting Period:
- 2016-03-03
- Filing Date:
- 2016-03-07
- Accepted Time:
- 2016-03-07 17:33:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1017491 | Apricus Biosciences Inc. | APRI | Pharmaceutical Preparations (2834) | 870449967 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1361754 | J Alexander Denner | C/O Sarissa Capital Management Lp 660 Steamboat Road Greenwich CT 06830 | No | No | Yes | No | |
1575277 | Sarissa Capital Domestic Fund Lp | C/O Sarissa Capital Management Lp 660 Steamboat Road Greenwich CT 06830 | No | No | Yes | No | |
1577524 | Sarissa Capital Management Lp | 660 Steamboat Road Greenwich CT 06830 | No | No | Yes | No | |
1577530 | Sarissa Capital Offshore Master Fund Lp | C/O Sarissa Capital Management 660 Steamboat Road Greenwich CT 06830 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-03-03 | 6,647,728 | $0.88 | 14,479,053 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrants to Purchase Common Stock | Acquisiton | 2016-03-03 | 3,323,864 | $0.00 | 3,323,864 | $0.88 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
6,724,525 | 2016-09-04 | 2023-03-03 | No | 4 | P | Indirect |
Footnotes
- See Exhibit 99.1; Note 1.
- See Exhibit 99.1; Note 2.
- See Exhibit 99.1; Note 3.